Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 topical nasal gel for allergic rhinitis
ACTRN12612001093875Phase 2Not yet recruiting
- Sponsor
- Syneos Health
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RT001 in allergic rhinitis (AR) and seasonal allergic rhinitis (SAR), sponsored by Syneos Health. Planned start Oct 2012; status: not yet recruiting.
02
Drugs
RT001
03
Conditions
allergic rhinitis (AR)seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ACTRN12612001093875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001093875.